2008
DOI: 10.1001/archneurol.2007.62
|View full text |Cite
|
Sign up to set email alerts
|

Reversible Posterior Leukoencephalopathy Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
392
1
16

Year Published

2008
2008
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 233 publications
(420 citation statements)
references
References 9 publications
11
392
1
16
Order By: Relevance
“…Reversible posterior leukoencephalopathy syndrome was first described by Hinchey et al 1 in 1996 and is characterized by headaches, visual disturbances, seizures, altered mental status and occasional focal signs. This entity has been reported in a variety of medical conditions including abrupt rise in blood pressure.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Reversible posterior leukoencephalopathy syndrome was first described by Hinchey et al 1 in 1996 and is characterized by headaches, visual disturbances, seizures, altered mental status and occasional focal signs. This entity has been reported in a variety of medical conditions including abrupt rise in blood pressure.…”
Section: Discussionmentioning
confidence: 99%
“…1 When promptly recognized and treated, symptoms and radiographic abnormalities are usually reversible. Occasionally if left untreated, this condition can lead to strokes and be fatal.…”
Section: Discussionmentioning
confidence: 99%
“…PRES was first described in 1996 by Hinchey et at. 7 . In this landmark paper, 15 patients were described to have a reversible syndrome characterized by headache, altered mental status, seizures, and loss of vision associated with imaging findings compatible with predominantly posterior white matter disease (leukoencephalopathy).…”
Section: Introductionmentioning
confidence: 99%
“…Hypotheses include cerebral ischemia from vasospasm, disordered cerebral autoregulation and endothelial dysfunction [1,2]. RPLS associated with calcineurin is thought to result from direct toxic injury to vascular endothelium, leading to production of inflammatory cytokines and capillary leakage, which triggers vasogenic cerebral edema [1,3,4]. Hypertension and high serum tacrolimus level are commonly associated with RPLS but there are reported RPLS cases with normal blood pressure and normal serum tacrolimus drug concentrations [5].…”
mentioning
confidence: 99%
“…Characteristic clinical manifestations include non-localized headache unresponsive to analgesics, altered mental status, visual disturbances and seizures [1,2]. RPLS is frequently associated with acute hypertension, preeclampsia or eclampsia, sepsis, renal failure, thrombotic thrombocytopenic purpura, hypercalcemia, hypomagnesium, autoimmune diseases, cytotoxic therapies and immunosuppressants [2].…”
mentioning
confidence: 99%